WuXi Biologics debuts new commercial drug product plant
Anticipated capacity of GMP facility is 60 million vials per year
Moderna to provide an additional 56.5 million vaccine doses to Gavi
A total of 116.5 million doses for low- and middle-income nations to arrive in Q2 of 2022
Cardinal Health granted FDA funding for RWE study
Award will support research based on use of real-world evidence in clinical oncology setting
People spotlight — October 2021
The latest people news happenings over the past month
Bionova Scientific introduces new GMP biologics manufacturing space
Additional equipment to be added to the plant next year
Aktana secures new machine learning automation technology
Acquisition reportedly increases AI accessibility across life sciences organizations
Catalent commits $230 million to Harmans gene therapy campus
Development project features additional manufacturing suites, expansion of storage capabilities
Biolife Solutions opens ‘Center of Excellence' in Amsterdam
Facility features cell storage for CAR-T cell treatments
Construction of new BioNTech manufacturing plant in Africa to begin mid-2022
mRNA jab maker plans to initially produce 50 million Covid vaccine doses per year
ten23 health acquires swissfillon
Deal provides ten23 with drug product development, biologic manufacturing experience
Waters, University of Delaware form bioprocessing collaboration
Agreement prioritizes ways to better distinguish biological manufacturing processes
EMA approves new Pfizer-BioNTech vaccine manufacturing sites, ready-to-use version of Comirnaty
Italian facilities will supply EU with up to 85 million doses of Covid jab
Avid Bioservices steps into viral vector development space
Biologics manufacturer to construct new C> facility to support expansion
Evergreen Theragnostics finishes New Jersey manufacturing plant
Facility meets cGMP standards for radiopharmaceutical production
WuXi ATU opens new manufacturing facility in Shanghai
CDTMO’s fourth site further expands its support of cell therapy delivery and access
PTC Therapeutics debuts new gene therapy manufacturing facility
Second NJ location will complement global HQ, offer plasmid DNA and AAV production services
Schreiner MediPharm one of ‘Alliance to Zero' founding members
Non-profit strives for pharma supply chain sustainability
MilliporeSigma unveils new viral vector facility
Second Carlsbad location expected to double CDMO’s production capacity
PCI acquires LSNE, adding fill-finishing to the mix
Transaction enhances CDMO’s services when it comes to drug product offerings
AavantiBio extends gene therapy partnership with University of Florida
Research collaboration centered around AAV capsids
Aceto acquires A&C Bio Buffer, expanding biopharma capabilities
Deal is expected to boost manufacturer’s European presence, Aceto executives say
Cambrex to invest $30M toward manufacturing center expansion
Among areas, financial commitment will power clinical and commercial manufacturing suites
AmerisourceBergen supports worldwide Covid vaccine distribution
Via its supply chain network, drug wholesaler has helped deliver more than 75 million vaccines
Global cold-chain expansions include ultracold storage, more packaging capacity
Marken/UPS, LifeScience Logistics and Packaging Technology Group are among the latest contenders
Moderna to build mRNA facility in Africa
Company officials predict 500 million vaccine doses per year to be produced via the center, which will offer fill-finish, packaging services
Science 37 begins trading on Nasdaq
Previous merger earns clinical research company $235 million as it looks to advance patient enrollment
Peli BioThermal moves its American HQ
Company officials believe new facility will help meet ongoing demand for temperature-controlled packaging
Syneos Health inks deal for RxDataScience
Using AI and data engineering insight, purchase offers customers potential to shorten clinical trials and accelerate time to commercialization
Report: Covid vaccine boosters, children’s doses ought to be outsourced
Pace of production plays a major role, says study
Thermo Fisher opens Swiss biologics site
Manufacturing facility to provide 1.5 million square feet of bioproduction technologies
